| Uniprot ID: | P17931 |
| Secondary ID: | B2RC38 |
| Symbol: | LGALS3 |
| Other Name: | MAC2,Gal-3,35 kDa lectin,Carbohydrate-binding protein 35,CBP 35,Galactose-specific lectin 3,Galactoside-binding protein,GALBP,IgE-binding protein,L-31,Laminin-binding protein,Lectin L-29,Mac-2 antigen |
| Class: | Single Protein |
| Type: | pro-fibrotic |
| Molecular Function: | IgE-binding protein |
Reference Record 1
Reference Record 2
| PubMed ID | 28431936 | Compound ID | |
| CAS | Name | ||
| Model | vitro,rat | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 3
| PubMed ID | 28322201 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human,mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 4
| PubMed ID | 27496875 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 5
| PubMed ID | 27630169 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting NLRP3 inflammasome/IL-1β production and IL-17 signaling | ||
Reference Record 6
| PubMed ID | 26351031 | Compound ID | |
| CAS | Name | ||
| Model | human,rat | Fibrosis Disease | Cardiac fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 7
| PubMed ID | 26313861 | Compound ID | |
| CAS | Name | ||
| Model | human | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 8
| PubMed ID | 26313861 | Compound ID | |
| CAS | Name | ||
| Model | human | Fibrosis Disease | Vascular fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 9
| PubMed ID | 23230309 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice,rat | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 10
| PubMed ID | 22306573 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | cells activation,cells accumulation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 11
| PubMed ID | 27870162 | Compound ID | |
| CAS | Name | ||
| Model | vitro,rat | Fibrosis Disease | Vascular fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting MMP-9 | ||